Earnings season is upon us again, and most public cannabis companies will release results for the 4th quarter of 2022 in the next few weeks. Only two of the companies in the graph have reported to date. Green Thumb (OTC: GTBIF) beat consensus revenue estimates by 1% and EBITDA estimates by 1.2%, while MariMed (OTC: MRMD) beat revenue estimates by 2% but missed EBITDA by 33.8%.


Full story available on Benzinga.com